When we think about dementia, we often think of a person experiencing memory loss and confusion. While it’s true that these ...
An estimated 6.7 million Americans over the age of 65 live with Alzheimer’s, so it's important to know the early signs of ...
Jacobin on MSNOpinion
How Big Pharma Turned FDA Approval Into a Rubber Stamp
Alberto Espay was not prepared for how his world would be upended when he published a study on the number of people who have ...
A new study shows that lecanemab, an amyloid-clearing Alzheimer’s therapy, does not improve the brain’s waste-removal network ...
13hon MSNOpinion
Anavex tumbles as Alzheimer’s therapy faces EU rejection
Anavex Life Sciences (AVXL) stock falls as the company faces a potential failure to win EU approval for its Alzheimer’s ...
In a new study, scientists discovered two FDA-approved cancer drugs that could also be effective at combatting one well-known ...
Stocktwits on MSN
AVXL Shares Slump Pre-market After EMA Committee Fails To Recommend Approval For Alzheimer’s Drug
Shares of Anavex Life Sciences (AVXL) slumped 8% in the premarket session on Friday after a European Medicines Agency (EMA) ...
A team of researchers at the Federal University of ABC (UFABC) in Brazil has developed a new chemical compound with the ...
News-Medical.Net on MSN
Amyloid-clearing drug fails to change waste clearance function in the brains of Alzheimer's patients
A group from Osaka Metropolitan University in Japan, led by graduate student Tatsushi Oura and Dr. Hiroyuki Tatekawa, found ...
Nurse practitioners play an essential role in diagnosing, treating, and supporting individuals living with Alzheimer disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results